Allworth Financial’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44K Sell
106
-224
-68% -$3.33K ﹤0.01% 4622
2026
Q1
$5.08K Buy
330
+108
+49% +$1.8K ﹤0.01% 3950
2025
Q4
$4K Buy
222
+6
+3% +$103 ﹤0.01% 3842
2025
Q3
$3.48K Buy
216
+71
+49% +$1.04K ﹤0.01% 3739
2025
Q2
$1.58K Buy
+145
New +$1.62K ﹤0.01% 3805

Other funds holding MESO

Allworth Financial's MESO Position: Q2 2026 in Review

Allworth Financial reduced its Mesoblast (MESO) stake by 68% in Q2 2026, selling an estimated $3.33K and leaving 106 shares worth $1.44K. The position accounts for ﹤0.01% of the portfolio, ranked #4622.

Allworth Financial first reported a position in MESO in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.08K in Q1 2026. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Allworth Financial held 106 shares of Mesoblast worth $1.44K as of Q2 2026.
  • Allworth Financial sold 224 Mesoblast shares in Q2 2026, an estimated $3.33K.
  • Mesoblast made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4622 holding.
  • Allworth Financial first reported a position in Mesoblast in Q2 2025 and has held it in 5 quarters since.
  • Allworth Financial's Mesoblast position peaked at $5.08K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.